Alembic Pharmaceuticals Shows High Trading Activity Amid Sector Resilience
Alembic Pharmaceuticals Ltd. has shown notable trading activity today, with a volume of 4,719,330 shares and a total value of approximately Rs 50.37 crore. The stock has outperformed its sector and remains above key moving averages, indicating a strong market position despite a slight decline in investor participation.
Alembic Pharmaceuticals Ltd. has emerged as one of the most active stocks today, reflecting significant trading activity in the pharmaceuticals and biotechnology sector. The stock, trading under the symbol APLLTD, recorded a total traded volume of 4,719,330 shares, with a total traded value of approximately Rs 50.37 crore. Opening at Rs 989.0, Alembic Pharmaceuticals saw a notable intraday high of Rs 1,095.0, marking a 12.4% increase from its previous close of Rs 968.9. The stock's performance today has outpaced its sector by 10.49%, showcasing its strong market position.
Despite the positive movement, there has been a slight decline in investor participation, with delivery volume dropping by 1.18% compared to the five-day average. However, the stock remains liquid enough for trading, with a liquidity level based on 2% of the five-day average traded value.
Currently, Alembic Pharmaceuticals is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a robust performance trend. Overall, Alembic Pharmaceuticals Ltd. has demonstrated significant activity and resilience in today's market, reflecting its strong standing within the industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
